药物信息为ORAVIG (miconazole) buccal tablets (Par Pharmaceuticals Companies, Inc.): 16 HOW SUPPLIED/STORAGE AND HANDLING
- 1 INDICATIONS AND USAGE
- 3 DOSAGE FORMS AND STRENGTHS
- 4 CONTRAINDICATIONS
- 6 ADVERSE REACTIONS
- 10 OVERDOSAGE
- 11 DESCRIPTION
- 14 CLINICAL STUDIES
- 16 HOW SUPPLIED/STORAGE AND HANDLING
- 17 PATIENT COUNSELING INFORMATION
- FDA-Approved Patient Labeling
- Principal Display Panel - Bottle Label
- Principal Display Panel - Carton Label
- Principal Display Panel - Bottle Label - 2 Tablet Professional SAMPLE
- Principal Display Panel - Carton Label - 2 Tablet Professional SAMPLE
- 外部链接相关的ORAVIG (miconazole) buccal tablets (Par Pharmaceuticals Companies, Inc.)
ORAVIG 50 mg buccal tablets are supplied as off-white tablets containing 50 mg of miconazole. ORAVIG tablets have a rounded side and a flat side. ORAVIG tablets are packaged in bottles of 14 tablets (NDC 49884-082-26).
ORAVIG should be stored at 20 to 25°C (68 to 77 °F) [see USP controlled room temperature] excursions between 15 and 30°C are permitted at room temperature. Protect from moisture, and keep out of reach of children.
- Drug Information Provided by National Library of Medicine (NLM).
